J M Knowlden

691 total citations
6 papers, 574 citations indexed

About

J M Knowlden is a scholar working on Oncology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J M Knowlden has authored 6 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J M Knowlden's work include HER2/EGFR in Cancer Research (5 papers), Estrogen and related hormone effects (4 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). J M Knowlden is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Estrogen and related hormone effects (4 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). J M Knowlden collaborates with scholars based in United Kingdom, Italy and United States. J M Knowlden's co-authors include Julia M.W. Gee, Denise Barrow, A. E. Wakeling, Robert I. Nicholson, Helen E. Jones, Stephen Hiscox, Michele Rubini, Lindy Goddard, Simon‐Peter Williams and Iain R. Hutcheson and has published in prestigious journals such as Oncogene, Annals of the New York Academy of Sciences and Endocrine Related Cancer.

In The Last Decade

J M Knowlden

6 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J M Knowlden United Kingdom 6 367 311 127 120 113 6 574
Thomas Frogne Denmark 9 217 0.6× 313 1.0× 149 1.2× 65 0.5× 69 0.6× 11 557
María C. Díaz Flaqué Argentina 14 314 0.9× 299 1.0× 96 0.8× 52 0.4× 80 0.7× 23 627
Pegram United States 2 355 1.0× 220 0.7× 230 1.8× 56 0.5× 140 1.2× 2 507
Carol M. Dutkowski United Kingdom 9 287 0.8× 329 1.1× 188 1.5× 87 0.7× 33 0.3× 14 544
Isabel Frahm Argentina 8 302 0.8× 290 0.9× 96 0.8× 35 0.3× 80 0.7× 12 607
Lois Witters United States 11 500 1.4× 262 0.8× 87 0.7× 100 0.8× 146 1.3× 19 668
P. Cannon United Kingdom 7 294 0.8× 181 0.6× 183 1.4× 53 0.4× 60 0.5× 10 496
Jacqueline C. Newby United Kingdom 4 276 0.8× 198 0.6× 213 1.7× 67 0.6× 81 0.7× 5 434
Christina M.W. Chan United Kingdom 9 160 0.4× 256 0.8× 259 2.0× 44 0.4× 73 0.6× 12 463
Karen Byer Eisenberg United States 12 266 0.7× 188 0.6× 296 2.3× 136 1.1× 84 0.7× 16 612

Countries citing papers authored by J M Knowlden

Since Specialization
Citations

This map shows the geographic impact of J M Knowlden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J M Knowlden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J M Knowlden more than expected).

Fields of papers citing papers by J M Knowlden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J M Knowlden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J M Knowlden. The network helps show where J M Knowlden may publish in the future.

Co-authorship network of co-authors of J M Knowlden

This figure shows the co-authorship network connecting the top 25 collaborators of J M Knowlden. A scholar is included among the top collaborators of J M Knowlden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J M Knowlden. J M Knowlden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nicholson, R.I., Iain R. Hutcheson, Stephen Hiscox, et al.. (2005). Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer. Endocrine Related Cancer. 12(Supplement_1). S29–S36. 53 indexed citations
2.
Jones, Helen E., Lindy Goddard, Julia M.W. Gee, et al.. (2004). Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocrine Related Cancer. 11(4). 793–814. 244 indexed citations
3.
Nicholson, R.I., Iain R. Hutcheson, M. E. Harper, et al.. (2001). Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.. Endocrine Related Cancer. 8(3). 175–182. 131 indexed citations
4.
Knowlden, J M, Julia M.W. Gee, Liam T. Seery, et al.. (1998). c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene. 17(15). 1949–1957. 107 indexed citations
5.
Knowlden, J M, Julia M.W. Gee, R A McClelland, et al.. (1997). Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.. PubMed. 3(11). 2165–72. 28 indexed citations
6.
Nicholson, Robert I., Julia M.W. Gee, R A McClelland, et al.. (1996). Pure Antiestrogens The Most Important Advance in the Endocrine Therapy of Breast Cancer since 1896?a. Annals of the New York Academy of Sciences. 784(1). 325–335. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026